Skip to content

Zoetis Inc Price, Chart & Factor Exposure

Free Data & Analytics Access

Latest earnings: November 5, 2026 results vs estimates

Zoetis Inc · E.ZTS.NYSE · United States
Use symbol E.ZTS.NYSE in our API & Excel add-in to retrieve this data ↓
78.80
(+0.01%)
? Live Prices updated every 5-seconds. Momentum Factor ranges from -100 to +100 and is the mean of four timeframe signals (1 Day, 1 Week, 1 Month, 3 Months), where each timeframe is +1 if return is above 0 and -1 otherwise. Trend Factor ranges from -100 to +100 and is the mean of eight signals across 1-month, 3-months, 6-months, and 1-year, using price vs moving average and moving average slope (+1 or -1). A rollover occurs when trend flips sign. Bubble Risk is the z-score of current price vs 1-year price: (Current Price - 250 trading days SMA) / (250 days price standard deviation). Values above +2.5 indicate overbought; below -2.5 oversold. Realized Volatility (20-days) is the standard deviation of daily returns over the past 20 trading days multiplied by sqrt(252).
Momentum 0%
Trend 25%
Bubble Risk LOW
Realised Volatility (20D) 27.60%

Zoetis Inc Forecast

Zoetis Inc short-term momentum is neutral (up over 2 of 4 look-backs: 5, 10, 20 and 30 trading days), a short-term NEUTRAL signal. The long-term trend is positive (5 of 8 checks up: price above, and slope of, its 50-, 100-, 150- and 200-day averages), a long-term BUY signal. Based on 20-day realised volatility of 27.6% a year, a typical one-standard-deviation range is 75.74–81.86 over a week, 72.52–85.08 over a month and 57.05–100.55 over a year. (Signals as of 1 Nov 2026.)

Zoetis Inc Price Chart

MacroFinance.ai
Market/MacroIndicatorNowChangeRange
Quantitative
Zoetis Inc
Momentum (composite)
—
ⓘLatest reading of Momentum (composite).
Zoetis Inc
Relative Volume (21d)
—
ⓘLatest reading of Relative Volume (21d).
Zoetis Inc
Signal
0
ⓘLatest reading of Signal.
Fundamental
Valuation
Zoetis Inc
P/E
13.05x
Cheap vs own history
QoQ +5.1%
YoY −36.1%
now 13.046711.13 low21.51 high
ⓘP/E As of 22 Nov 2026.See Zoetis Inc returns when P/E looked like now →Opens Return analysis with the filter P/E within ±5% of today
Zoetis Inc
P/S
3.41x
Cheap vs own history
QoQ 0.0%
YoY −40.7%
now 3.41123.06 low6.07 high
ⓘP/S As of 22 Nov 2026.See Zoetis Inc returns when P/S looked like now →Opens Return analysis with the filter P/S within ±5% of today
Zoetis Inc
P/B
9.82x
Cheap vs own history
QoQ −4.8%
YoY −2.0%
now 9.81969.25 low17.26 high
ⓘP/B As of 22 Nov 2026.See Zoetis Inc returns when P/B looked like now →Opens Return analysis with the filter P/B within ±5% of today
Zoetis Inc
EV/EBITDA
10.47x
Cheap vs own history
QoQ +4.4%
YoY −28.5%
now 10.4699.18 low15.81 high
ⓘEV/EBITDA As of 22 Nov 2026.See Zoetis Inc returns when EV/EBITDA looked like now →Opens Return analysis with the filter EV/EBITDA within ±5% of today
Zoetis Inc
EV/Sales
4.22x
Cheap vs own history
QoQ +0.4%
YoY −33.1%
now 4.22153.85 low6.81 high
ⓘEV/Sales As of 22 Nov 2026.See Zoetis Inc returns when EV/Sales looked like now →Opens Return analysis with the filter EV/Sales within ±5% of today
Zoetis Inc
FCF Yield
7.0%
Strong vs own history
QoQ −3.6%
YoY +69.6%
now 7.02353.94 low8.13 high
ⓘFCF Yield As of 22 Nov 2026.See Zoetis Inc returns when FCF Yield looked like now →Opens Return analysis with the filter FCF Yield within ±5% of today
Zoetis Inc
Earnings Yield
7.7%
Strong vs own history
QoQ −4.9%
YoY +56.4%
now 7.66484.65 low8.99 high
ⓘEarnings Yield As of 22 Nov 2026.See Zoetis Inc returns when Earnings Yield looked like now →Opens Return analysis with the filter Earnings Yield within ±5% of today
Zoetis Inc
Dividend Yield
2.7%
Strong vs own history
QoQ −0.2%
YoY +71.2%
now 2.73171.52 low3.05 high
ⓘDividend Yield As of 22 Nov 2026.See Zoetis Inc returns when Dividend Yield looked like now →Opens Return analysis with the filter Dividend Yield within ±5% of today
Zoetis Inc
Market Cap
$32.4B
Lowest in 5 years
QoQ −0.1%
YoY −40.0%
now 32434.0829,110 low57,500 high
ⓘMarket Cap As of 22 Nov 2026.See Zoetis Inc returns when Market Cap looked like now →Opens Return analysis with the filter Market Cap within ±5% of today
Balance-Sheet Health
Zoetis Inc
Net Debt
$7.7B
High vs own history
QoQ +1.9%
YoY +48.5%
now 77045,189 low7,704 high
ⓘNet Debt As of 22 Nov 2026.See Zoetis Inc returns when Net Debt looked like now →Opens Return analysis with the filter Net Debt within ±5% of today
Zoetis Inc
Net Debt / EBITDA
2.01x
High vs own history
QoQ +6.1%
YoY +56.9%
now 2.00941.28 low2.01 high
ⓘNet Debt / EBITDA As of 22 Nov 2026.See Zoetis Inc returns when Net Debt / EBITDA looked like now →Opens Return analysis with the filter Net Debt / EBITDA within ±5% of today
Zoetis Inc
Current Ratio
2.35x
Mid-range vs own history
QoQ −23.9%
YoY −35.6%
now 2.34642.35 low3.64 high
ⓘCurrent Ratio As of 22 Nov 2026.See Zoetis Inc returns when Current Ratio looked like now →Opens Return analysis with the filter Current Ratio within ±5% of today
Zoetis Inc
Quick Ratio
1.40x
Mid-range vs own history
QoQ −23.7%
YoY −38.5%
now 1.40081.4 low2.28 high
ⓘQuick Ratio As of 22 Nov 2026.See Zoetis Inc returns when Quick Ratio looked like now →Opens Return analysis with the filter Quick Ratio within ±5% of today
Zoetis Inc
Interest Coverage
13.87x
Mid-range vs own history
QoQ −3.6%
YoY −7.7%
now 13.867813.87 low15.09 high
ⓘInterest Coverage As of 22 Nov 2026.See Zoetis Inc returns when Interest Coverage looked like now →Opens Return analysis with the filter Interest Coverage within ±5% of today
Zoetis Inc
Debt / Equity
2.80x
High vs own history
QoQ −4.7%
YoY +107.6%
now 2.79651.35 low2.93 high
ⓘDebt / Equity As of 22 Nov 2026.See Zoetis Inc returns when Debt / Equity looked like now →Opens Return analysis with the filter Debt / Equity within ±5% of today
Zoetis Inc
Piotroski F-Score
5
Weak vs own history
QoQ −16.7%
YoY −16.7%
now 55 low7 high
ⓘPiotroski F-Score As of 22 Nov 2026.See Zoetis Inc returns when Piotroski F-Score looked like now →Opens Return analysis with the filter Piotroski F-Score within ±5% of today
Zoetis Inc
Altman Z-Score
4.72
Weak vs own history
QoQ −0.4%
YoY −25.8%
now 4.71734.57 low6.52 high
ⓘAltman Z-Score As of 22 Nov 2026.See Zoetis Inc returns when Altman Z-Score looked like now →Opens Return analysis with the filter Altman Z-Score within ±5% of today
  19 members-only factors: Revenue Growth, Revenue CAGR 3Y, Earnings Growth, EBITDA Growth and moreSign up
Accounting Red Flags
  21 members-only factors: Sloan Accruals, Cash-Earnings Gap, Beneish M-Score, Days Sales in Receivables Index and moreSign up
Global Risk
  22 members-only factors: MacroFinance Risk Index, VIX, VSTOXX, VIX Term Structure and moreSign up
Teal = supportive for Zoetis Inc, red = a headwind, grey = neutral. Hover or tap ⓘ for how each factor works and to see returns in similar conditions.

Zoetis Inc fundamentals: income statement, balance sheet & cash flow

Zoetis Inc reported revenue of $9.47bn and net income of $2.67bn in FY2025, the year ended 31 December 2025 — revenue up 2.3% and net income up 7.5% on the prior year. Free cash flow was $2.28bn. These figures are as reported in the filings, not restated: 17 fiscal years and 64 quarters of history, back to December 2009. 173 FINRA short-interest settlements are published alongside them, back to June 2019.

Revenue (FY2025)
$9.47bn
+2.3%
Net income
$2.67bn
+7.5%
Gross margin
70.49%
Free cash flow
$2.28bn
-0.7%
Net debt
$6.99bn
Shares short (30 Oct 2026)
16.72m
4.78 days to cover
Zoetis Inc income statement, annual, as reported · USD millions unless stated
USD millionsFY2025FY2024FY2023FY2022FY2021
Period end31 Dec 202531 Dec 202431 Dec 202331 Dec 202231 Dec 2021
Revenue9,467.09,256.08,544.08,080.07,776.0
Cost of revenue2,794.02,860.02,710.02,604.02,464.0
Gross profit6,673.06,396.05,834.05,476.05,312.0
Research & development698.0686.0614.0539.0508.0
Selling, general & admin.2,378.0————
Operating income3,597.03,392.03,069.02,928.02,803.0
EBITDA4,069.03,872.03,685.03,358.03,172.0
Interest expense243.0242.0258.0237.0236.0
Pre-tax income3,360.03,133.02,936.02,656.02,488.0
Income tax687.0637.0596.0545.0454.0
Net income2,673.02,486.02,344.02,114.02,037.0

Download Zoetis Inc fundamentals

Get the fundamentals as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_fundamentals&symbol=E.ZTS.NYSE&statement=all&freq=a&format=csv&years=10
DownloadLast 10 fiscal years, no login.
The free download stops at 10 fiscal years. A free account unlocks all 17 fiscal years and 64 quarters, the filing vintages behind each number and API access.
Create free account

Figures in USD, statements as filed and FINRA consolidated short interest. A cell is left blank where the filing does not report it or where the reported figure fails the statement’s own arithmetic. Short interest is the consolidated FINRA figure for the settlement date shown, published seven to eight business days later.

Research on Zoetis Inc

Explore MacroFinance macro & markets research and analysis.

Browse all financial research →

Zoetis Inc Trading Strategies

58 backtested tactical asset allocation strategies hold SPY (US market) or XLV (Health Care sector), the closest tradable exposure to Zoetis Inc; 28 of them are invested now. Strategies currently invested are listed first.

Hypothetical backtests over each ETF's own history; past performance does not guarantee future results. Upgrade to see every strategy's allocation and performance.

From creators

See all 58 strategies holding SPY, XLV →

Statistical Distribution of Returns

Plus

How Zoetis Inc’s returns are distributed — and how they change in a given market regime.

Regime filters

Market/Macro Indicator Criteria Value And (for Between) Action

No regime filter yet — the chart below shows every period. Add a factor condition, or pick a popular regime.

MacroFinance.ai
Full return statistics
Statistic All periods Matching
  Sharpe, maximum drawdown and the full percentile table are part of Plus. Unlock with Plus
Know how Zoetis Inc behaves before the regime turns Plus unlocks the full return history, unlimited factor conditions, regime-versus-baseline statistics and export — on every market, stock, ETF and index.

About Zoetis Inc (United States)

Zoetis Inc is a listed security in the United States. This page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data (the last 10 years as CSV or JSON, no login).

Last updated: November 22, 2026

More on BMO Short-Term US Treasury Bond

Frequently asked questions

What is Zoetis Inc?
Zoetis Inc is a listed security in the United States. On MacroFinance its page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data.
What is the latest Zoetis Inc price?
The latest close is 78.8 (1 Nov 2026), +0.01% on the day. The price at the top of the page refreshes during the trading day.
Is Zoetis Inc in an uptrend?
As of 1 Nov 2026, short-term momentum is neutral (2 of 4 look-backs up: 5, 10, 20 and 30 trading days) and the long-term trend is positive (5 of 8 checks up on its 50- to 200-day moving averages). Bullish when both are positive, bearish when both are negative.
How volatile is Zoetis Inc?
20-day realised volatility is 27.6% a year (1 Nov 2026), which implies a typical one-standard-deviation move of about 8.0% over a month and 3.9% over a week.
What factors affect Zoetis Inc?
The Factors section lists the signals, relative-value, risk-model and macro factors linked to Zoetis Inc, grouped as Quantitative Factors, Fundamental Factors, Accounting Red Flags, Global Risk Factors, each with its latest reading. Some factors are open to everyone; the rest need a MacroFinance plan.
Which trading strategies trade Zoetis Inc?
58 backtested tactical asset allocation strategies trade Zoetis Inc through SPY, XLV; 28 of them hold it now. The Trading Strategies section lists them with their current weight, CAGR, Sharpe ratio and maximum drawdown.
How are Zoetis Inc returns analysed?
The Statistical Distribution of Returns section shows the distribution of Zoetis Inc daily, weekly, monthly, 2-month and 3-month returns with count, annualised average return, volatility, Sharpe ratio and maximum drawdown, and lets you filter the history by factor conditions, e.g. only periods when momentum was positive. A free account tests up to 2 factor conditions over the last 1 year of history; a Plus plan unlocks the full history, unlimited conditions, the regime statistics and the export.
Where can I download free Zoetis Inc historical data?
In the Free historical data section of this page: the last 10 years of Zoetis Inc daily closes as CSV or JSON, no login needed. A free account unlocks the full history, Excel and API access.

Free Zoetis Inc historical data (last 10 years)

Browse or instantly download the last 10 years of Zoetis Inc daily price history. A free account unlocks the full history, an Excel export with factors, and API access.

Get the data as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_history&symbol=E.ZTS.NYSE&format=csv&years=10
DownloadLast 10 years, no login.
DateClose
2026-11-2079.11
2026-11-1980.79
2026-11-1885.57
2026-11-1783.48
2026-11-1684.39
2026-11-1383.82
2026-11-1282.96
2026-11-1182.57
2026-11-1082.46
2026-11-0982.32
Loading last 10 years…
The table and downloads stop at 10 years. A free account unlocks the full history, the Excel add-in and API access.
Create free account

About this stock

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally. The company commercializes products primarily across companion animals comprising dogs, cats, and horses; and species, including livestock, such as cattle, swine, poultry, fish, and sheep. It also offers parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaborated with Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was incorporated in 2012 and is headquartered in Parsippany, New Jersey.